CRISPR-Cas9 system: a novel and promising era of genotherapy for beta-hemoglobinopathies, hematological malignancy, and hemophilia

Authors	Alayoubi Abdulfatah M., Khawaji Zakaria Y., Mohammed Mohammed A., Mercier François E.
Journal	Annals of Hematology
Publication Date	2024-06-00
DOI	10.1007/s00277-023-05457-2

Research Projects

Cell Lines

• YCMi001-B
• YCMi001-B-1